Time
Days to earnings13
Next print2026-10-29
WindowBMO
Fiscal2026-09-30
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 13 | 2026-10-29 | 98.56 | -0.365 | 55.1% | 11.9% | -5.1% | -16.2% | -21.3% | -16.9% | 0.039 / -0.90 | 257.3% | 17 | 0.57 | 0 | |
| 2026-10-09 | 14 | 2026-10-29 | 100.60 | -0.365 | 50.8% | 11.9% | -9.5% | -14.6% | -22.3% | -17.1% | 0.039 / -0.90 | 257.3% | 17 | 0.58 | 0 | |
| 2026-10-08 | 15 | 2026-10-29 | 100.48 | -0.365 | 51.7% | 12.4% | -7.5% | -17.3% | -21.1% | -19.2% | 0.039 / -0.90 | 257.3% | 17 | 0.58 | 0 | |
| 2026-10-07 | 16 | 2026-10-29 | 101.74 | -0.365 | 49.3% | 12.1% | -10.9% | -14.0% | -21.0% | -17.9% | 0.039 / -0.90 | 257.3% | 17 | 0.66 | 0 | |
| 2026-10-06 | 17 | 2026-10-29 | 105.23 | -0.365 | 49.8% | 12.5% | -9.0% | -12.9% | -15.7% | -15.1% | 0.039 / -0.90 | 257.3% | 17 | 0.68 | 0 | |
| 2026-10-05 | 18 | 2026-10-29 | 103.83 | -0.365 | 45.9% | 11.8% | -11.8% | -14.2% | -17.8% | -17.4% | 0.039 / -0.90 | 257.3% | 17 | 0.68 | 0 | |
| 2026-10-02 | 19 | 2026-10-29 | 111.12 | -0.359 | 45.9% | 12.5% | -5.7% | -7.4% | -12.3% | -11.2% | 0.039 / -0.90 | 261.2% | 17 | 0.69 | 0 | |
| 2026-10-01 | 20 | 2026-10-29 | 108.59 | -0.359 | 44.9% | 12.4% | -10.7% | -12.4% | -14.2% | -16.9% | 0.039 / -0.90 | 261.2% | 17 | 0.70 | 0 | |
| 2026-09-30 | 21 | 2026-10-29 | 114.14 | -0.359 | 40.5% | 11.4% | -3.5% | -6.9% | -6.1% | -11.1% | 0.039 / -0.90 | 261.2% | 17 | 0.74 | 0 | |
| 2026-09-29 | 22 | 2026-10-29 | 115.63 | -0.359 | 44.4% | 12.7% | -4.3% | -3.6% | -5.1% | -9.9% | 0.039 / -0.90 | 261.2% | 17 | 0.70 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| AMGN primary | Amgen Inc | 0.14 | 2026Q2 · 2026-08-04 | +12.3% | +0.9% | 407.83 | 16 · 2026-10-12 |
| GILD primary | Gilead Sciences Inc | 0.13 | 2026Q2 · 2026-08-03 | +4.5% | 0.0% | 135.25 | 13 · 2026-10-12 |
| ALNY primary | Alnylam Pharmaceuticals Inc | 0.12 | 2026Q2 · 2026-07-30 | -16.0% | -21.5% | 205.48 | 13 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-06 | BMO | -0.52 | +24.6% | Beat | +29.5% | +3.4% | 4.19× | -5.6% | Review |
| 2026Q1 | 2026-05-07 | BMO | -0.76 | +24.0% | Beat | -14.7% | -10.2% | 8.61× | +4.3% | Review |
| 2025Q4 | 2026-02-19 | BMO | -1.54 | -31.6% | Miss | +1.8% | +4.7% | 2.36× | -10.8% | Review |
| 2025Q3 | 2025-10-30 | BMO | -1.75 | -27.7% | Miss | +2.6% | +13.4% | 3.77× | -1.7% | Review |
| 2025Q2 | 2025-08-07 | BMO | -1.70 | -30.8% | Miss | -4.2% | +2.6% | 1.28× | +21.3% | Review |
| 2025Q1 | 2025-05-08 | BMO | -1.42 | -18.3% | Miss | -0.6% | -3.3% | 1.10× | +0.8% | Review |
| 2024Q4 | 2025-02-20 | BMO | -1.32 | -7.3% | Miss | -4.4% | +4.4% | 1.27× | -10.3% | Review |
| 2024Q3 | 2024-10-31 | BMO | -1.27 | -4.1% | Miss | -2.4% | -1.9% | 2.42× | +5.9% | Review |
| 2024Q2 | 2024-08-08 | BMO | -1.94 | -57.7% | Miss | -2.7% | +4.0% | 0.99× | +10.0% | Review |
| 2024Q1 | 2024-05-09 | BMO | -1.06 | +11.7% | Beat | +8.9% | -6.8% | 1.67× | -10.5% | Review |